308 related articles for article (PubMed ID: 28540991)
1. Comparison of Efficacy of Intravenous Peramivir and Oral Oseltamivir for the Treatment of Influenza: Systematic Review and Meta-Analysis.
Lee J; Park JH; Jwa H; Kim YH
Yonsei Med J; 2017 Jul; 58(4):778-785. PubMed ID: 28540991
[TBL] [Abstract][Full Text] [Related]
2. Comparing intravenous peramivir with oral oseltamivir for patients with influenza: a meta-analysis of randomized controlled trials.
Fang YH; Hsu TH; Lin TY; Liu CH; Chou SC; Wu JY; Perng PC
Expert Rev Anti Infect Ther; 2021 Aug; 19(8):1039-1046. PubMed ID: 33641583
[TBL] [Abstract][Full Text] [Related]
3. Phase III randomized, double-blind study comparing single-dose intravenous peramivir with oral oseltamivir in patients with seasonal influenza virus infection.
Kohno S; Yen MY; Cheong HJ; Hirotsu N; Ishida T; Kadota J; Mizuguchi M; Kida H; Shimada J;
Antimicrob Agents Chemother; 2011 Nov; 55(11):5267-76. PubMed ID: 21825298
[TBL] [Abstract][Full Text] [Related]
4. A Meta-Analysis Comparing the Efficacy and Safety of Peramivir with Other Neuraminidase Inhibitors for Influenza Treatment.
Chen JY; Wei SK; Lai CC; Weng TS; Wang HH
Medicina (Kaunas); 2020 Feb; 56(2):. PubMed ID: 32033501
[TBL] [Abstract][Full Text] [Related]
5. Peramivir is as effective as oral oseltamivir in the treatment of severe seasonal influenza.
Yoo JW; Choi SH; Huh JW; Lim CM; Koh Y; Hong SB
J Med Virol; 2015 Oct; 87(10):1649-55. PubMed ID: 25946636
[TBL] [Abstract][Full Text] [Related]
6. A clinical trial of intravenous peramivir compared with oral oseltamivir for the treatment of seasonal influenza in hospitalized adults.
Ison MG; Hui DS; Clezy K; O'Neil BJ; Flynt A; Collis PJ; Simon TJ; Alexander WJ
Antivir Ther; 2013; 18(5):651-61. PubMed ID: 23111657
[TBL] [Abstract][Full Text] [Related]
7. Peramivir: A Review in Uncomplicated Influenza.
Scott LJ
Drugs; 2018 Sep; 78(13):1363-1370. PubMed ID: 30196350
[TBL] [Abstract][Full Text] [Related]
8. Clinical efficacy of peramivir in adult patients with seasonal influenza during the winter of 2012 in Japan.
Yoshino Y; Seo K; Koga I; Kitazawa T; Ota Y
Clin Respir J; 2015 Apr; 9(2):228-32. PubMed ID: 24612842
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and tolerability of the oral neuraminidase inhibitor peramivir in experimental human influenza: randomized, controlled trials for prophylaxis and treatment.
Barroso L; Treanor J; Gubareva L; Hayden FG
Antivir Ther; 2005; 10(8):901-10. PubMed ID: 16430195
[TBL] [Abstract][Full Text] [Related]
10. [Clinical efficiency in children treated with intravenous drip infusion of peramivir].
Sakata H
Jpn J Antibiot; 2011 Dec; 64(6):383-7. PubMed ID: 22686008
[TBL] [Abstract][Full Text] [Related]
11. Single dose peramivir for the treatment of acute seasonal influenza: integrated analysis of efficacy and safety from two placebo-controlled trials.
Whitley R; Laughlin A; Carson S; Mitha E; Tellier G; Stich M; Elder J; Alexander WJ; Dobo S; Collis P; Sheridan WP
Antivir Ther; 2015; 20(7):709-19. PubMed ID: 25318121
[TBL] [Abstract][Full Text] [Related]
12. Clinical effectiveness of neuraminidase inhibitors--oseltamivir, zanamivir, laninamivir, and peramivir--for treatment of influenza A(H3N2) and A(H1N1)pdm09 infection: an observational study in the 2010-2011 influenza season in Japan.
Shobugawa Y; Saito R; Sato I; Kawashima T; Dapat C; Dapat IC; Kondo H; Suzuki Y; Saito K; Suzuki H
J Infect Chemother; 2012 Dec; 18(6):858-64. PubMed ID: 22644080
[TBL] [Abstract][Full Text] [Related]
13. Improvement of respiratory symptoms and health-related quality of life with peramivir in influenza patients with chronic respiratory disease: Additional outcomes of a randomized, open-label study.
Kato M; Saisho Y; Tanaka H; Bando T
Influenza Other Respir Viruses; 2021 Sep; 15(5):651-660. PubMed ID: 33683019
[TBL] [Abstract][Full Text] [Related]
14. Post-marketing safety evaluation of the intravenous anti-influenza neuraminidase inhibitor peramivir: A drug-use investigation in patients with high risk factors.
Komeda T; Ishii S; Itoh Y; Sanekata M; Yoshikawa T; Shimada J
J Infect Chemother; 2016 Oct; 22(10):677-84. PubMed ID: 27497712
[TBL] [Abstract][Full Text] [Related]
15. Absence of pharmacokinetic interaction between intravenous peramivir and oral oseltamivir or rimantadine in humans.
Atiee G; Lasseter K; Baughman S; McCullough A; Collis P; Hollister A; Hernandez J
J Clin Pharmacol; 2012 Sep; 52(9):1410-9. PubMed ID: 21960669
[TBL] [Abstract][Full Text] [Related]
16. Clinical and virologic effects of four neuraminidase inhibitors in influenza A virus-infected children (aged 4-12 years): an open-label, randomized study in Japan.
Hirotsu N; Saisho Y; Hasegawa T; Shishido T
Expert Rev Anti Infect Ther; 2018 Feb; 16(2):173-182. PubMed ID: 29284320
[TBL] [Abstract][Full Text] [Related]
17. Intravenous peramivir for treatment of influenza in hospitalized patients.
Ison MG; Fraiz J; Heller B; Jauregui L; Mills G; O'Riordan W; O'Neil B; Playford EG; Rolf JD; Sada-Diaz E; Elder J; Collis P; Hernandez JE; Sheridan WP
Antivir Ther; 2014; 19(4):349-61. PubMed ID: 23985625
[TBL] [Abstract][Full Text] [Related]
18. Intravenous peramivir inhibits viral replication, and leads to bacterial clearance and prevention of mortality during murine bacterial co-infection caused by influenza A(H1N1)pdm09 virus and Streptococcus pneumoniae.
Onishi M; Kitano M; Taniguchi K; Homma T; Kobayashi M; Yoshinaga T; Naito A; Sato A
Antiviral Res; 2015 May; 117():52-9. PubMed ID: 25752738
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of peramivir for influenza treatment.
Hata A; Akashi-Ueda R; Takamatsu K; Matsumura T
Drug Des Devel Ther; 2014; 8():2017-38. PubMed ID: 25368514
[TBL] [Abstract][Full Text] [Related]
20. Intravenous peramivir vs oral oseltamivir in high-risk emergency department patients with influenza: Results from a pilot randomized controlled study.
Hsieh YH; Dugas AF; LoVecchio F; McBryde B; Ricketts EP; Saliba-Shaw K; Rothman RE
Influenza Other Respir Viruses; 2021 Jan; 15(1):121-131. PubMed ID: 33006445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
